Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Eder T, Weber A, Neuwirt H, Grunbacher G, Ploner C, Klocker H et al
Unlike TB-500 (Thymosin Beta-4 fragment), which acts primarily via G-actin sequestration and endothelial progenitor cell mobilization, BPC-157 exerts its action via an NO-dependent pathway and VEGFR2 modulation two distinct but potentially complementary mechanisms, which is why research protocols sometimes combine both peptides (synergy documented in animal tendon repair models)
J.AntoineD
Medical Classification: Class 1 Medicine Efficacy: Contains Tranexamic Acid, effective in improving dark spots (limited to melasma)
US$ 29.09
US$ 22.87
US$ 21.05
